An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice

Gastroenterology

Volumn 143, Issue 5, 2012, Pages 1298-1307

  Forster, Katharina ^a   Goethel, Ashleigh ^a   Chan, Catherine Wing Tak ^a   Zanello, Galliano ^a   Streutker, Catherine ^b   Croitoru, Kenneth ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

IFN ; IL 6; TGF ; TNF

Indexed keywords

CD3 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 6; MONOCLONAL ANTIBODY CD3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCID MOUSE; T LYMPHOCYTE ACTIVATION; WASTING SYNDROME;

EID: 84868110120     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.07.019     Document Type: Article

References (46)

1. P.L. Lakatos Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 12 2006 6102 6108
2. N.J. Talley, M.T. Abreu, J.P. Achkar An evidence-based systematic review on medical therapies for inflammatory bowel disease Am J Gastroenterol 106 Suppl 1 2011 S2 S25
3. J.K. Triantafillidis, E. Merikas, F. Georgopoulos Current and emerging drugs for the treatment of inflammatory bowel disease Drug Des Dev Ther 5 2011 185 210
4. A.M. Faria, H.L. Weiner Oral tolerance Immunol Rev 206 2005 232 259
5. A.M. Faria, H.L. Weiner Oral tolerance: therapeutic implications for autoimmune diseases Clin Dev Immunol 13 2006 143 157
6. W. Strober, B. Kelsall, T. Marth Oral tolerance J Clin Immunol 18 1998 1 30
7. H.L. Weiner, A.P. da Cunha, F. Quintana Oral tolerance Immunol Rev 241 2011 241 259
8. H. Ochi, M. Abraham, H. Ishikawa Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ Nat Med 12 2006 627 635
9. H. Ochi, M. Abraham, H. Ishikawa New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity J Neurol Sci 274 2008 9 12
10. P. Zhou, R. Borojevic, C. Streutker Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens J Immunol 172 2004 1515 1523
11. D.V. Ostanin, J. Bao, I. Koboziev T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade Am J Physiol Gastrointest Liver Physiol 296 2009 G135 G146
12. F. Powrie, R. Correa-Oliveira, S. Mauze Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity J Exp Med 179 1994 589 600
13. K. Geddes, S.J. Rubino, J.G. Magalhaes Identification of an innate T helper type 17 response to intestinal bacterial pathogens Nat Med 17 2011 837 844
14. H. Ishikawa, H. Ochi, M.L. Chen Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody Diabetes 56 2007 2103 2109
15. H.Y. Wu, E.M. Center, G.C. Tsokos Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells Lupus 18 2009 586 596
16. H.Y. Wu, R. Maron, A.M. Tukpah Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant J Immunol 185 2010 3401 3407
17. M. Merger, J.L. Viney, R. Borojevic Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine Gut 51 2002 155 163
18. Y. Ilan, R. Maron, A.M. Tukpah Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice Proc Natl Acad Sci U S A 107 2010 9765 9770
19. A. al-Sabbagh, A. Miller, L.M. Santos Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse Eur J Immunol 24 1994 2104 2109
20. A. al-Sabbagh, P.A. Nelson, Y. Akselband Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen Cell Immunol 171 1996 111 119
21. Y. Chen, V.K. Kuchroo, J. Inobe Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265 1994 1237 1240
22. Y. Chen, J. Inobe, V.K. Kuchroo Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells Proc Natl Acad Sci U S A 93 1996 388 391
23. A.M. Faria, R. Maron, S.M. Ficker Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin- 10 and suppression of experimental autoimmune encephalomyelitis J Autoimmun 20 2003 135 145
24. J. Inobe, A.J. Slavin, Y. Komagata IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis Eur J Immunol 28 1998 2780 2790
25. A. Miller, O. Lider, H.L. Weiner Antigen-driven bystander suppression after oral administration of antigens J Exp Med 174 1991 791 798
26. A. Miller, O. Lider, A. al-Sabbagh Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V. Hierarchy of suppression by myelin basic protein from different species J Neuroimmunol 39 1992 243 250
27. A. Miller, O. Lider, A.B. Roberts Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering Proc Natl Acad Sci U S A 89 1992 421 425
28. A. Miller, A. al-Sabbagh, L.M. Santos Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression J Immunol 151 1993 7307 7315
29. A. Miller, Z.J. Zhang, R.A. Sobel Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization J Neuroimmunol 46 1993 73 82
30. H. Groux, A. O'Garra, M. Bigler A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
31. P.A. Ruiz, A. Shkoda, S.C. Kim IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis J Immunol 174 2005 2990 2999
32. P.A. Ruiz, A. Shkoda, S.C. Kim IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation Ann N Y Acad Sci 1072 2006 389 394
33. L.V. Rizzo, R.A. Morawetz, N.E. Miller-Rivero IL-4 and IL-10 are both required for the induction of oral tolerance J Immunol 162 1999 2613 2622
34. P.A. Gonnella, H.P. Waldner, D. Kodali Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis J Autoimmun 23 2004 193 200
35. D.A. Vignali, L.W. Collison, C.J. Workman How regulatory T cells work Nat Rev Immunol 8 2008 523 532
36. A.M. Thornton, P.E. Korty, D.Q. Tran Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells J Immunol 184 2010 3422 3441
37. H. Fukaura, S.C. Kent, M.J. Pietrusewicz Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients J Clin Invest 98 1996 70 77
38. T. Oida, X. Zhang, M. Goto CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45Rbhi-induced colitis by a TGF-beta dependent mechanism J Immunol 170 2003 2516 2522
39. M.G. Roncarolo, S. Gregori, M. Battaglia Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol Rev 212 2006 28 50
40. M. Battaglia, B.R. Blazar, M.G. Roncarolo The puzzling world of murine T regulatory cells Microbes Infect 4 2002 559 566
41. M. Battaglia, C. Gianfrani, S. Gregori IL-10-producing T regulatory type 1 cells and oral tolerance Ann N Y Acad Sci 1029 2004 142 153
42. M. Battaglia, M.G. Roncarolo The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells Transplantation 77 2004 S16 S18
43. M. Battaglia, A. Stabilini, E. Draghici Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells Diabetes 55 2006 1571 1580
44. M. Battaglia, S. Gregori, R. Bacchetta Tr1 cells: from discovery to their clinical application Semin Immunol 18 2006 120 127
45. M. Battaglia, A. Stabilini, E. Draghici Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance Diabetes 55 2006 40 49
46. H.Y. Wu, F.J. Quintana, A.P. da Cunha In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling PLoS One 6 2011 e23618